The General Commissioner of the State Food and Drug Administration (“SFDA”) unveiled six key priorities of the agency in 2011 at the General Assembly of Food and Drug Administrations in China.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
China's new SFDA priorities
To view this article you need a PDF viewer such as Adobe Reader.
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.
Senior Patent Counsel
Royal DSM NV